Daniel Heng MD, MPH FRCPC
Clinical Associate Professor, University of Calgary Chair,
Southern Alberta GU Tumor
Bruce Gowin
Advanced RCC Patient
“Take the kidney out, it’s all gone, you live happily ever after, to, yeah, this didn’t work so well. And it was very disappointing, of course.
Nothing anybody can do about it. Move on from there. What’s next?”
~ Bruce Gowin, Advanced RCC Patient
“Immunotherapy for treatment of cancers has been around for a very long time. We actually used to use immunotherapy a lot to treat advanced kidney cancers until the targeted therapy era came, where we used pills to treat the kidney cancer instead. But now, there has been a re-emergence of immuno – oncology agents, next-generation checkpoint inhibitors that actually rev up a patient’s immune system, so that the immune system attacks their own tumor. And, they’ve been able to extend survival, improve quality of life, and really revolutionize how we treat kidney cancer today.”
Daniel Heng, MD
Clinical Associate Professor, University of Calgary
Find out more at the link below: